Rafael Contreras-Galindo

发表

NGSQC: cross-platform quality analysis pipeline for deep sequencing data

Robert C. Thompson, G. Omenn, D. Markovitz, 2010, BMC Genomics.

The Genomic Landscape of Centromeres in Cancers

S. Malek, D. Markovitz, M. Kaplan, 2019, Scientific Reports.

The Genomic Landscape of Centromeres in Cancers

S. Malek, D. Markovitz, M. Kaplan, 2018 .

Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.

D. Markovitz, N. Mor-Vaknin, H. Broxmeyer, 2019, The Journal of clinical investigation.

Genomic flexibility of human endogenous retrovirus type K

Marta J. Gonzalez-Hernandez, D. Markovitz, M. Kaplan, 2013, Retrovirology.

The role of the histone H3 variant CENPA in prostate cancer

A. Chinnaiyan, G. Omenn, S. Tomlins, 2020, The Journal of Biological Chemistry.

The Genomic Landscape of Centromeres in Various Cancers

S. Malek, D. Markovitz, M. Kaplan, 2018, bioRxiv.

The Chromatin Remodeler HELLS: A New Regulator in DNA Repair, Genome Maintenance, and Cancer

Z. Lewis, Wioletta Czaja, Rafael Contreras-Galindo, 2022, International journal of molecular sciences.

Centromere defects, chromosome instability, and cGAS-STING activation in systemic sclerosis

D. Markovitz, M. Kaplan, D. Khanna, 2022, Nature Communications.

The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells

J. Rual, D. Markovitz, O. Reiner, 2019, PloS one.

HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses

Manhong Dai, Gilbert S Omenn, Fan Meng, 2013, Genome research.

Regulation of the Human Endogenous Retrovirus K (HML-2) Transcriptome by the HIV-1 Tat Protein

G. Omenn, Marta J. Gonzalez-Hernandez, D. Markovitz, 2014, Journal of Virology.

Expression of Human Endogenous Retrovirus Type K (HML-2) Is Activated by the Tat Protein of HIV-1

M. Swanson, Marta J. Gonzalez-Hernandez, D. Markovitz, 2012, Journal of Virology.

Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K–Related Sequences

G. Omenn, Marta J. Gonzalez-Hernandez, D. Markovitz, 2015, Journal of Virology.

Human Endogenous Retrovirus K Gag Coassembles with HIV-1 Gag and Reduces the Release Efficiency and Infectivity of HIV-1

Mark H. Kaplan, D. Markovitz, M. Kaplan, 2012, Journal of Virology.

release efficiency and infectivity of HIV-1

D. Markovitz, M. Kaplan, A. Ono, 2012 .

Rapid molecular assays to study human centromere genomics

A. Chinnaiyan, G. Omenn, D. Markovitz, 2017, Genome research.

A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens.

Rafael Contreras-Galindo, Y. Yamamura, E. Lorenzo, 2006, Journal of virological methods.

Gitlin and David M. Markovitz Lymphoma and Breast Cancer Elements in the Plasma of People with Human Endogenous Retrovirus K (hml-2) Supplemental Material

D. Markovitz, D. Hayes, M. Kaplan, 2008 .

Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.

D. Markovitz, M. Kaplan, Rafael Contreras-Galindo, 2006, AIDS research and human retroviruses.

HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro.

Rafael Contreras-Galindo, Y. Yamamura, Pablo López, 2007, AIDS research and human retroviruses.

Expansion of a novel endogenous retrovirus throughout the pericentromeres of modern humans

G. Omenn, D. Markovitz, M. Kaplan, 2015, Genome Biology.

Genomic flexibility of human endogenous retrovirus type K

Marta J. Gonzalez-Hernandez, D. Markovitz, M. Kaplan, 2013, Journal of Virology.

Short Communication: Comparative Longitudinal Studies of HERV-K and HIV-1 RNA Titers in HIV-1-Infected Patients Receiving Successful versus Unsuccessful Highly Active Antiretroviral Therapy

Rafael Contreras-Galindo, Y. Yamamura, E. Lorenzo, 2007 .

Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors

D. Markovitz, M. Kaplan, K. Fujinaga, 2017, Journal of Virology.

Characterization of Human Endogenous Retroviral Elements in the Blood of HIV-1-Infected Individuals

Mark H. Kaplan, Ilaria Ferlenghi, Marta J. Gonzalez-Hernandez, 2011, Journal of Virology.

Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy.

Rafael Contreras-Galindo, Y. Yamamura, E. Lorenzo, 2007, AIDS research and human retroviruses.

Is the HERV-K HML-2 Xq21.33, an endogenous retrovirus mutated by gene conversion of chromosome X in a subset of African populations, associated with human breast cancer?

S. Merajver, A. Chinnaiyan, C. Adebamowo, 2020, Infectious Agents and Cancer.

Structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous T-cell lymphoma, Sézary syndrome, and HIV infection

James T. Elder, M. Kaminski, C. Adebamowo, 2019, BMC Medical Genomics.

Is the HERV-K HML-2 Xq21.33, an endogenous retrovirus mutated by gene conversion of chromosome X in a subset of African populations, associated with human breast cancer?

S. Merajver, A. Chinnaiyan, C. Adebamowo, 2020, Infectious Agents and Cancer.

Expression of Human Endogenous Retrovirus Type K (HML-2) Is Activated by the Tat Protein of HIV-1

M. Swanson, Marta J. Gonzalez-Hernandez, D. Markovitz, 2012, Journal of Virology.

Human Endogenous Retrovirus K (HML-2) Elements in the Plasma of People with Lymphoma and Breast Cancer

D. Markovitz, D. Hayes, M. Kaplan, 2008, Journal of Virology.